Radiofrequency Non-ablative in the Treatment of Genitourinary Syndrome of Menopause

Launched by CENTRO DE ATENÇÃO AO ASSOALHO PÉLVICO · Apr 23, 2018

Keywords

ClinConnect Summary

This clinical trial is studying a treatment for women who are experiencing Genitourinary Syndrome of Menopause (GSM), which can cause discomfort in the vaginal area and urinary problems after menopause. The researchers are testing a non-invasive technique called radiofrequency therapy. This involves using a special device that gently heats the vaginal area to help improve symptoms. Women participating in the trial will receive five treatment sessions, each lasting about 20 minutes, with a week between each session. A trained physical therapist will perform the treatments while monitoring the temperature to ensure safety and effectiveness.

To join the trial, participants need to be women under 65 years old who are experiencing symptoms of GSM and are willing to take part in the study. However, women with certain health issues, such as neurological diseases or those using specific medical devices, will not be eligible. Throughout the trial, participants will also undergo assessments to evaluate their symptoms and monitor any changes. This study aims to provide more options for women dealing with uncomfortable symptoms related to menopause.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • will be women in menopause until 65 years of age with clinical complaints of Genitourinary Syndrome of Menopause and who agree to voluntarily participate in the research.
• Exclusion Criteria:
• • will be excluded from the study participants with limited understanding, with neurological degenerative chronic diseases, sensory deficit in the genital region, users of pacemaker and intrauterine device of cooper and women under hormone therapy under six months